Stocks and Investing Stocks and Investing
Tue, November 8, 2022

Derek Archila Maintained (CCCC) at Hold with Decreased Target to $11 on, Nov 8th, 2022


Published on 2024-10-28 00:00:34 - WOPRAI, Derek Archila
  Print publication without navigation


Derek Archila of Wells Fargo, Maintained "C4 Therapeutics, Inc." (CCCC) at Hold with Decreased Target from $12 to $11 on, Nov 8th, 2022.

Derek has made no other calls on CCCC in the last 4 months.



There are 2 other peers that have a rating on CCCC. Out of the 2 peers that are also analyzing CCCC, 1 agrees with Derek's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Eric Joseph of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $15 on, Friday, November 4th, 2022


This is the rating of the analyst that currently disagrees with Derek


  • Terence Flynn of "Morgan Stanley" Initiated at Sell and Held Target at $6 on, Tuesday, October 11th, 2022

Contributing Sources